GlassScriptPhysician profile
Jason Reingold
NPI 1639374283
$35,527.65
in general payments reported to CMS, 2019-2025
21 companies · $390 in 2025
The $390 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $8,093 · 2022: $4,593 · 2023: $158 · 2024: $98.39 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $646.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $34,273.67 | 2019-2022 | |
| Pfizer INC. | $233.21 | 2019-2023 | |
| Inari Medical, INC. | $189.06 | 2022 | |
| Amgen INC. | $123.89 | 2023-2025 | Repatha, Repatha |
| Heartflow, INC. | $99.01 | 2025 | |
| Boston Scientific Corporation | $94.24 | 2022-2025 | Watchman Access System, Varithena Administration Pack |
| Abbott Laboratories | $86.86 | 2022-2024 | Mitraclip |
| Novartis Pharmaceuticals Corporation | $79.29 | 2019-2022 | |
| Novo Nordisk INC | $71.45 | 2022-2023 | Ozempic, Rybelsus |
| Vital Connect, INC | $54.19 | 2025 | Vitalpatch Rtm |
| Merck Sharp & Dohme LLC | $38.25 | 2023-2025 | Verquvo |
| Abiomed | $33.92 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $23.47 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $20.35 | 2024 | Opsumit |
| Lilly USA, LLC | $16.67 | 2025 | Zepbound |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $16.65 | 2025 | Inspire |
| Baxter Healthcare | $16.60 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Cleerly, INC. | $16.03 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Philips North America LLC | $15.19 | 2022 | |
| Irhythm Technologies, INC. | $13.88 | 2023 | Zio Xt Patch |
| Kowa Pharmaceuticals America, INC. | $11.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Reingold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.